English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/78772
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Immunoaffinity, Capillary Electrophoresis, and Statistics for Studying Intact Alpha 1-Acid Glycoprotein Isoforms as an Atherothrombosis Biomarker

AuthorsPuerta, Angel de la ; Martín-Álvarez, Pedro J. ; Ongay, Sara ; Diez-Masa, Jose Carlos; Frutos, Mercedes de
Issue Date2013
PublisherHumana Press
CitationClinical Applications of Capillary Electrophoresis (Cap.20): 215-230 (2013)
SeriesMethods in Molecular Biology 919
AbstractVariations in the amino acid sequence, glycosylation, and/or other posttranslational modifications in glycoproteins give rise to different molecules of the glycoprotein called forms. Qualitative and/or quantitative alterations in these forms are related to pathophysiological situations in the individuals. In this study, a methodology to analyze these differences in forms of the alpha 1-acid glycoprotein (AGP) between healthy individuals and patients with two different vascular diseases is detailed. The whole methodology includes a sample preparation method based on immunochromatography, a capillary electrophoresis method for separation of AGP peaks (isoforms), and statistical methods (Linear Discriminant Analysis) for sample classification. As a result, it is shown that the methodology proposed allows studying the role of AGP isoforms as potential vascular disease biomarkers.
URIhttp://hdl.handle.net/10261/78772
DOI10.1007/978-1-62703-029-8_20
ISBN978-1-62703-028-1
Appears in Collections:(IQOG) Libros y partes de libros
(CIAL) Libros y partes de libros
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.